¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nervous System Autoimmune Disease, Experimental"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • gamma chain disease
    °¨¸¶»ç½½º´
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûº´, ´ç¿øÃàÀûº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • Greenfield¡¯s disease
    ±×¸°Çʵ庴
  • Hartnup¡¯s disease
    ÇÏÆ®³Òº´
  • Hashimoto¡¯s disease
    ÇϽøðÅ亴
  • hyperendemic disease
    °ú´ÙºóµµÇ³Å亴, °ú´ÙÁö¹æÀ¯Çິ
  • hypertensive disease
    °íÇ÷¾Ðº´
  • hypertensive heart disease
    °íÇ÷¾Ð½ÉÀ庴, °íÇ÷¾Ð½ÉÀåÁúȯ
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
  • heart disease
    ½ÉÀ庴
  • heart muscle disease
    ½ÉÀå±ÙÀ°º´, ½É±ÙÁúȯ
  • heavy-chain disease
    ¹«°Å¿î»ç½½º´, Á߼⺴
  • hemoglobin C disease
    Çì¸ð±Û·ÎºóCº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • disease taxonomy
    Áúº´ºÐ·ùÇÐ
  • disease vector
    Áúº´¸Å°³Ã¼
  • disease free survival
    ¹«º´»ýÁ¸
  • disease frequency survey
    Áúº´ºóµµÁ¶»ç
  • disease odds ratio
    Áúº´±³Â÷ºñ
  • dust disease
    ¸ÕÁöº´
  • endemic disease
    dzÅ亴
  • enzootic disease
    µ¿¹°ÅäÂøº´
  • epidemic disease
    À¯Çິ
  • epidermal-epithelial viral disease
    Ç¥ÇÇ»óÇǹÙÀÌ·¯½ºº´
  • exotic disease
    ¿Ü·¡º´
  • extraarticular rheumatic disease
    °üÀý¿Ü·ù¸¶Æ¼½ºº´
  • extrapyramidal disease
    Ãßü¿Ü·Îº´
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ
  • febrile disease
    ¿­º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • Hirschsprung s disease
    Ç츣½¬½ºÇÁ·îº´.
  • Hirschsprungs disease
    È÷¸£½¬½ºÇÁ·îº´
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Huntingtons disease
    ÇãÆÃÅæ¹«µµº´
  • Huntingtons disease
    ÇåÆÃÅæ º´
  • Hyaline membrane disease
    À¯¸®Áú¸·º´(ë¤×ãòõدܻ)
  • Internation Classification of Disease(ICD)
    ±¹Á¦Áúº´ºÐ·ù.
  • Jacob-Creutzfeldt disease
    ¾ßÄß-Å©·çÃ÷ÆçÆ®º´
  • Johnes disease
    ÁÔÁúȯ
  • Kahler s disease
    Ä®·¯º´.
  • Kawasaki disease
    °¡¿Í»ç³¢º´, Á¡¸·ÇǺθ²ÇÁÀý ÁõÈıº (±Þ¼º¿­¼º)
  • Kawasaki disease => mucocutaneous lymph node syndrome
    °¡¿Í»çŰ º´
  • Kimura disease
    ±â¹«¶ó º´
  • Krabbe s disease
    Å©¶óº£º´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • health care delivery system
    ÀÇ·áÀü´ÞÁ¦µµ(ËöËíËøËÀ̡̬).
  • health care system
    º¸°ÇÀÇ·áü°è.
  • health information system
    º¸°ÇÁ¤º¸Ã¼°è.
  • heterogeneous system
    ºÒ±ÕÀϰè, ºÒ±ÕÁú°è.
  • hexagonal system
    À°¹æ°áÁ¤°è.
  • homogeneous system
    ±ÕÁú°è, ±ÕÀϰè.
  • hormonopoietic system
    È£¸£¸ó»ý¼º°è.
  • hospital information system
    º´¿øÁ¤º¸Ã¼°è.
  • hydrophilic system
    Ä£¼ö°è(öÑâ©Í§).
  • hydrophobic system
    ¼Ò¼ö°è.
  • hypophyseal portal system
    ³úÇϼöü¹®¸Æ°èÅë, Çϼöü¹®¸Æ°è(¡­Ú¦ØæÍ§).
  • hypothalamohypophyseal portal system
    ½Ã»óÇϺγúÇϼöü¹®¸Æ°è.
  • hypothalamohypophyseal system
    ½Ã»óÇϺγúÇϼöü°è.
  • hypothalamopituitary system
    ½Ã»óÇϺγúÇϼöü°è.
  • hypothalamus pituaitary system
    ½Ã»óÇϺγúÇϼöü°è.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
SD Sandhoff disease; senile dementia; septal defect; serologically defined; serologically detectable; s...
SVD single vessel disease; singular value decomposition; small vessel disease; spontaneous vaginal deliv...
WD wallerian degeneration; well developed; well differentiated; wet dressing; Whitney Damon [dextrose];...
AHA Autoimmune Hemolytic Anemia
APECED Autoimmune Poly-Endocrinopathy Candidiasis Ectodermal Dystrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
EMS Emergency Medical System
ES Expert System
FARS Fatal Accident Reporting System
FS Functional System
GITS GASTROINTESTINAL THERAPEUTIC SYSTEM
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • consumption disease
    ¼Ò¸ð¼º Áúȯ
    ü·ÂÀÇ ¼Ò¸ð. Àü¿¡´Â Æó °áÇÙ¿¡ ´ëÇÏ¿© »ç¿ëµÇ¾ú´Ù.
  • Creutzfeldt-Jakob disease
    ¾ß°ö º´
    ÁßÃ߽Űæ°è¸¦ ħ¹üÇÏ´Â ¹ÙÀÌ·¯½º¼º °¨¿° Áúȯ. Ä¡¸Å°¡ ¿À°Ô µÇ°í °£´ë¼º °æ·ÃÀ» º¸ÀÌ´Ù°¡ »ç¸ÁÇÏ°Ô µÇ´Â °£¿°¼º ÁúȯÀÌ´Ù. Àü¼¼°èÀûÀ¸·Î ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, Å©·ÎÀÌÃ÷ÆçÆ®-¾ß°ö º´À̶ó°íµµ ÇÑ´Ù. Àü¿° °æ·Î´Â È®½ÇÇÏ°Ô ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª, 1996³â ¿µ±¹¿¡¼­ ¹ßº´ÇÑ ±¤¿ìº´
  • Crohn's disease
    Crohn Áúȯ, Å©·Ð¾¾ º´, Å©·Ð º´
    Å©·ÐÀÌ 1932³â óÀ½À¸·Î ȸÀå ¸»´ÜÀÇ Àå¿°À» ±¹ÇÑÀû ȸÀå¿°À¸·Î ±âÀçÇÑ °Í. ȸÀå ¸»´Ü¿°. ¼ÒÀå, ´ëÀå¿¡¼­µµ º¼ ¼ö ÀÖÀ¸¸ç ȸÀå ¸»´ÜºÎÀÇ °ÅÀÇ 30cm¿¡ ÀÚÁÖ ¹ß»ýÇϰí Á¡¸·¿¡¼­ Á¡¸· ÇÏÃþ¿¡ ¹ÌÄ¡´Â ¿°Áõ¼º º¯È­·Î À°¾Æ °Å´ë¼¼Æ÷¸¦ º¼ ¼ö ÀÖ´Ù. ¿øÀÎÀº Àå³» ¼¼±Õ, ¾Ë·¯Áö µîÀÇ ¿¬°üµÈ °ÍÀ¸·Î º¸ÀδÙ.
  • cyanotic heart disease
    û»ö¼º ½ÉÀå Áúȯ
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë¼º ºÀÀÔü º´, °Å´ë ¼¼Æ÷ ºÀÀÔü Áúȯ
  • cytomegaloviral disease
    °Å´ë ¼¼Æ÷ ¹ÙÀÌ·¯½º Áúȯ
  • Darier's disease
    ´ë¸®¾î º´
    µ¿ÀǾî=
  • degenerative brain disease
    ÅðÇ༺ ³ú Áúȯ
  • degenerative disease
    ÅðÇ༺ Áúȯ
  • degenerative joint disease
    ÅðÇ༺ °üÀý Áúȯ
    °üÀý ±¸Á¶¹°¿¡ ÀûÀÀ ÇѰ踦 ³Ñ¾î¼­´Â ÈûÀÌ °è¼Ó °¡ÇØÁö¸é °üÀý¸é, Ȱ¸·, °üÀý³¶¿¡ ¿°Áõ¼º º´º¯ÀÌ »ý±â´Â °æ¿ì.
  • demyelination disease
    Å»¼öÃÊ Áúȯ
    ½Å°æ¿¡ ¼öÃʰ¡ ¾ø¾î¼­ µµ¾à Àüµµ°¡ ÀϾÁö ¾Ê¾Æ ¾ß±âµÇ´Â Áúȯµé.
  • dercums disease
    ´õÄÄ º´
  • devics disease
    µ¥ºò º´
    µ¿ÀǾî=o
  • digestive tract disease
    ¼ÒÈ­±â °èÅë Áúȯ
  • disease
    º´, Áúº´, Áúȯ
    ÀÎÁö °¡´ÉÇÑ ÀÏ·ÃÀÇ Â¡ÈÄ¿Í Áõ»ó, ½Åü ¼Ò°ßÀÌ Æ¯Â¡ÀÎ Áúº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
expert system Expert systems are computer programs designed to simulate the problem-solving behaviour of human experts within very narrow domains or scientific disciplines (entomology, plant pathology, etc.).
This discipline is a sub-set of Artificial Intelligence.
See: artificial intelligence.
Synonym: knowledge-based systems
(13 Jan 1998)
expression system <molecular biology> Combination of an expression vector, its cloned DNA, and the host for the vector that provide a context to allow foreign gene function in a host cell, that is, produce proteins at a high level.
(13 Nov 1997)
exterofective system Name applied by Cannon to the somatic nervous system as opposed to the interofective or autonomic system.
(05 Mar 2000)
extrapyramidal motor system Literally: all of the brain structures affecting bodily (somatic) movement, excluding the motor neurons, the motor cortex, and the pyramidal (corticobulbar and corticospinal) tract. Despite its very wide literal connotation, the term is commonly used to denote in particular the striate body (basal ganglia), its associated structures (substantia nigra; subthalamic nucleus), and its descending connections with the midbrain.
(05 Mar 2000)
kallikrein-kinin system A system produced in the distal nephron of the kidney. Its components are kallikrein, kinins, kininase I and II, and enkephalinase. It is involved in mediation and modulation of the renin-angiotensin-aldosterone system, prostaglandins, vasopressins, and in the regulation of sodium-water balance, renal haemodynamics, and particularly blood pressure. The system participates in the control of renal functions and the physiopathology of renal diseases.
(12 Dec 1998)
kallikrein system A blood serum system, the activity of which is initiated by factor XII (Hageman factor) leading to the production of prekallikrein activator and then to kallikrein which, after activation by plasmin, splits bradykinin from kininogen.
(05 Mar 2000)
kidd blood-group system A group of antigens consisting principally of jk(a) and jk(b), determined by allelic genes. Amorphs are encountered. Antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes.
(12 Dec 1998)
Zaffaroni system A chromatographic system for the separation of steroids.
(05 Mar 2000)
unified medical language system A research and development program initiated by the national library of medicine to build an intelligent automated system that can understand biomedical concepts, words, and expressions and their interrelationships, and use this understanding to help users retrieve and organise information from a variety of machine-readable sources. The goal of the umls is to compensate for differences in the terminology of the disparate systems and for variations in user modes of expression. The umls project has produced four knowledge sources meant to be used by user interface programs. These are the metathesaurus, the semantic network, the information sources map, and the specialist lexicon.
(12 Dec 1998)
kinetic system A term proposed by G.W. Crile to denote the chain of organs through which latent energy is transformed into motion and heat: it includes the brain, the thyroid, the adrenals, the liver, the pancreas, and the muscles, that part of the neuromuscular system whereby active movements are effected; distinguished from the static system.
(05 Mar 2000)
feedback system A complex of neuronal circuits whereby a part of the efferent path returns to the input to modulate its activity, thus acting as a governor on the system.
See: feedback.
(05 Mar 2000)
urinary system The organs concerned in the production and excretion of urine, together with the organs of reproduction.
(12 Dec 1998)
urogenital system The organs concerned in the production and excretion of urine, together with the organs of reproduction.
(12 Dec 1998)
uropoietic system The kidneys, ureters, bladder, and urethra, considered as a system for the secretion and excretion of urine.
(05 Mar 2000)
filling defect in renal collecting system <radiology> Common causes: transitional cell carcinoma, blood clot, lucent calculus (urate) less common causes: fungus ball, sloughed papilla, fibroepithelial polyp, invasion by hypernephroma, malakoplakia, vessel impression, metastases
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á